Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Trusted by the world's smartest companies to:
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Let's see how we can help you!
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Latest Psilocin Pharma News
Expert: Psilocybin Is Like Penicillin for the Brain, Rewiring It to Generate New Neurological Pathways
Oct 12, 2021
Michael Frank, CEO of Revive Therapeutics, and Derrick Welsh, COO of Psilocin Pharma, a division of Revive Therapeutics, discuss clinical research investigating novel treatment targets for psilocybin, such as treatment-resistant depression in patients with cancer.
Jun 17, 2021
Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of PsychedelicsPsilocin Pharma Frequently Asked Questions (FAQ)
What is Psilocin Pharma's latest funding round?
Psilocin Pharma's latest funding round is Acquired.
Who are the investors of Psilocin Pharma?
Investors of Psilocin Pharma include Revive Therapeutics.
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Trusted by the world's smartest companies to:
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Let's see how we can help you!
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
